Abstract
Introduction
Guidelines and local hospital protocols dealing with anticoagulation at the time of surgery vary, but most suggest stopping Warfarin at least three days preoperatively with or without interim low-molecular-weight heparin or intravenous heparin infusion. This study addresses whether it is safe to perform inguinal hernia surgery on the patient who is fully anticoagulated with Warfarin.
Methods
We performed a retrospective case note analysis of consecutive patients who underwent elective inguinal hernia repair at the Plymouth Hernia Service between 1999 and 2007. All patients on therapeutic oral anticoagulation with Warfarin were selected. Data analysis was of complications and patient-related, hernia-related, and surgery-related variables. International normalising ratio (INR) was measured on the day preceding surgery.
Results
A total of 49 patients had been operated on whilst anticoagulated with Warfarin. The mean age of the patients was 75 years (range 44–96 years). Thirty patients were on Warfarin for atrial fibrillation, seven for previous PE, three for previous DVT, and nine for mechanical heart valves. Forty patients had a desired INR range of 2–3, and nine a desired range of 3–4. Forty-five (91.8%) patients had no complications or mild bruising requiring no further management. Three (6.1%) patients developed haematomas requiring surgical management and there was one death of unrelated cause. An INR of greater than 3 increased the risk of postoperative haematoma (P = 0.03). None of the other measured patient-related, hernia-related, or surgery-related variables predicted complications (P > 0.05).
Conclusions
Patients can safely undergo inguinal hernia repair whilst on Warfarin as long as the INR is less than 3.
Similar content being viewed by others
References
Watts SA, Gibbs NM (2003) Outpatient management of the chronically anticoagulated patient for elective surgery. Anaesth Intensive Care 31:145–154
(1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449–1457
(1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 342:1255–1262
Cannegieter SC, Rosendaal FR, Briet E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89:635–641
Kearon C, Hirsh J (1997) Management of anticoagulation before and after elective surgery. N Engl J Med 336:1506–1511
Dunn AS, Turpie AG (2003) Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 163:901–908
TPC Mumme, Lorenz N, Junge K, Schumpelick V (2000) Does anticoagulation increase the risk of wound hematoma in inguinal hernia surgery? Hernia 4:275–281
Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H (1995) A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 332:1661–1665
(1992) Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society. Lancet 340:873–876
Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P et al (1995) Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 74:606–611
Caplan LR, Hier DB, D’Cruz I (1983) Cerebral embolism in the Michael Reese Stroke Registry. Stroke 14:530–536
Anderson CS, Jamrozik KD, Broadhurst RJ, Stewart-Wynne EG (1994) Predicting survival for 1 year among different subtypes of stroke. Results from the Perth Community Stroke Study. Stroke 25:1935–1944
Dunn AS, Spyropoulos AC, Turpie AG (2007) Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 5:2211–2218
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sanders, D.L., Shahid, M.K., Ahlijah, B. et al. Inguinal hernia repair in the anticoagulated patient: a retrospective analysis. Hernia 12, 589–592 (2008). https://doi.org/10.1007/s10029-008-0405-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10029-008-0405-x